Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
MAFLD and glomerular hyperfiltration in subjects with prediabetes, visceral obesity and “preserved” kidney function: A cross-sectional study
Aneliya Parvanova, Manuela Abbate, Aina M. Yáñez, Miquel Bennasar‐Veny, Ángel Arturo López‐González, José Ignacio Ramírez‐Manent, Ilian Iliev, Sergio Fresneda, María Arias-Fernández, Giuseppe Remuzzi, Piero Ruggenenti (2023). MAFLD and glomerular hyperfiltration in subjects with prediabetes, visceral obesity and “preserved” kidney function: A cross-sectional study. , 201, DOI: https://doi.org/10.1016/j.diabres.2023.110729.
Article42 days agoGlomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial
Fabiola Carrara, Piero Ruggenenti, Annalisa Perna, Ilian Iliev, Flavio Gaspari, Silvia Ferrari, Nadia Stucchi, Antonio Bossi, Roberto Trevisan, Giuseppe Remuzzi, Aneliya Parvanova (2021). Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial. , 59(3), DOI: https://doi.org/10.1007/s00592-021-01804-9.
Article42 days agoPreventing microalbuminuria with benazepril, valsartan, and benazepril–valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study
Piero Ruggenenti, Monica Cortinovis, Aneliya Parvanova, Matias Trillini, Ilian Iliev, Antonio Bossi, Antonio Belviso, M Aparicio, Roberto Trevisan, Stefano Rota, Annalisa Perna, Tobia Peracchi, Nadia Rubis, Davide Martinetti, Silvia Prandini, Flavio Gaspari, Fabiola Carrara, Salvatore De Cosmo, Giancarlo Tonolo, Ruggero Mangili, Giuseppe Remuzzi (2021). Preventing microalbuminuria with benazepril, valsartan, and benazepril–valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study. , 18(7), DOI: https://doi.org/10.1371/journal.pmed.1003691.
Article42 days agoEffects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial
Piero Ruggenenti, Matias Trillini, Draženka Pongrac Barlovič, Monica Cortinovis, Antonio Pisani, Aneliya Parvanova, Ilian Iliev, Barbara Ruggiero, Stefano Rota, M Aparicio, Annalisa Perna, Francesco Peraro, Olimpia Diadei, Flavio Gaspari, Fabiola Carrara, Nadia Stucchi, Davide Martinetti, Andrej Janež, Nadan Gregorič, Eleonora Riccio, Antonio Bossi, Roberto Trevisan, Paolo Manunta, Giovanni Giorgio Battaglia, S. David, Filippo Aucella, Antonio Belviso, Andrea Satta, Giuseppe Remuzzi (2019). Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial. , 21(5), DOI: https://doi.org/10.1111/dom.13639.
Article42 days agoImpact of a Complement Factor H Gene Variant on Renal Dysfunction, Cardiovascular Events, and Response to ACE Inhibitor Therapy in Type 2 Diabetes
Elisabetta Valoti, Marina Noris, Annalisa Perna, Erica Rurali, Giulia Gherardi, Matteo Breno, Aneliya Parvanova, Ilian Iliev, Antonio Bossi, Roberto Trevisan, Alessandro Roberto Dodesini, Silvia Ferrari, Nadia Stucchi, Ariela Benigni, Giuseppe Remuzzi, Piero Ruggenenti (2019). Impact of a Complement Factor H Gene Variant on Renal Dysfunction, Cardiovascular Events, and Response to ACE Inhibitor Therapy in Type 2 Diabetes. , 10, DOI: https://doi.org/10.3389/fgene.2019.00681.
Article42 days ago